Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 11, 2024 09:54 ET | Source: Coloplast A/S

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier

Se venligst vedlagte pdf. Vedhæftet fil 11122024_handel_med_aktier_GL ...
December 11, 2024 09:54 ET | Source: Coloplast A/S

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Please see enclosed pdf. Attachment 11122024_trading_in_shares_GL ...
December 05, 2024 11:11 ET | Source: Coloplast A/S

Coloplast A/S - Beslutninger på den ordinære Generalforsamling 2024

I dag, den 5. december 2024, har Coloplast A/S afholdt ordinær generalforsamling, hvor følgende beslutninger blev vedtaget: Årsrapporten for regnskabsåret 2023/24 blev godkendt.Forslag om...
December 05, 2024 11:11 ET | Source: Coloplast A/S

Coloplast A/S - Decisions at the Annual General Meeting 2024

Today, 5 December 2024, Coloplast A/S held its Annual General Meeting, at which the following resolutions were adopted: The annual report for the financial year 2023/24 was approved.Distribution of...
December 04, 2024 07:01 ET | Source: Coloplast A/S

Coloplast frasælger kerneprodukter i hudplejeforretningen

Frasalget sker som led i et strategisk initiativ, der skal forenkle driften og forbedre lønsomheden i forretningsområdet Avanceret Sårpleje. Omsætningen fra de frasolgte produkter i...
December 04, 2024 07:01 ET | Source: Coloplast A/S

Coloplast divests core Skin Care product portfolio

The divestment is part of a strategic initiative to simplify business operations and improve profitability in the Advanced Wound Care business area. Revenue from the core Skin Care business amounted...
November 14, 2024 08:22 ET | Source: Coloplast A/S

Kerecis included on the list of covered products for Diabetic Foot Ulcers in the final LCD policy

On 14 November 2024, the U.S. Centers for Medicare & Medicaid Services (CMS) issued a final Local Coverage Determination (LCD)1 policy regarding skin substitute grafts/cellular and tissue-based...
November 12, 2024 06:01 ET | Source: Coloplast A/S

Coloplast A/S - Indkaldelse til ordinær generalforsamling 2024

Den ordinære generalforsamling i Coloplast A/S afholdestorsdag den 5. december 2024 kl. 15:30på Coloplast A/S’ adresse, Holtedam 3 (Aage Louis-Hansen Auditorium), Humlebæk, Danmark.Indkaldelsen...
November 12, 2024 06:01 ET | Source: Coloplast A/S

Coloplast A/S - Notice of Annual General Meeting 2024

The Annual General Meeting of Coloplast A/S will be held onThursday, 5 December 2024 at 3:30 pm CETat the premises of Coloplast A/S, Holtedam 3 in Humlebæk (the Aage Louis-Hansen Auditorium),...
November 05, 2024 01:28 ET | Source: Coloplast A/S

Coloplast A/S - Annual Report 2023/24 & Remuneration Report 2023/24

Coloplast A/S - Annual Report 2023/24 & Remuneration Report 2023/24 FY 2023/24 organic growth of 8% and 27% EBIT margin1. Reported revenue in DKK grew 10% to DKK 27,030 million. Organic...